2007 2010 DEA Patients 
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD. Lyle Craker, Ph.D., Source: [link].
Cannabis Law Report
JULY 12, 2019
Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Meadow
JULY 13, 2018
Back in 2007, it said we don’t want anymore cannabis businesses and despite a general prohibition, we still had more cannabis businesses than any other location. We’ve had a cap on that really since 2010 and one way or another, we’ve codified that now to a number of 30. It’s every square inch of it.
Cannabis Law Report
MARCH 25, 2019
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 3, 2010 , 124 Stat. 2003, 2004, 2007, 2008, Nov. 109–248, title II , § ? 611 ; Pub. 110–425 , § ?
The Joint Blog
JUNE 2, 2020
A patient or a leisure seeker should be mindful of the cannabis laws, otherwise your trip to paradise might end up in a nightmare. Remember that he made a similar comment in May 2017 when signing that fiscal year’s appropriations bill into law, and yet no raids against state-legal medical marijuana patients or providers followed.
Expert insights. Personalized for you.
52 
Let's personalize your content